Barrientos-Ruiz Irene, Ortiz-Cruz Eduardo José, Peleteiro-Pensado Manuel
La Paz University Hospital, Paseo de la Castellana 261, Madrid, Spain.
MD Anderson International Hospital, Madrid, Spain.
Clin Orthop Relat Res. 2017 Mar;475(3):735-741. doi: 10.1007/s11999-016-4747-x.
Reconstruction after internal hemipelvectomy resection likely provides better function than hindquarter amputation. However, many reconstruction methods have been used, complications with these approaches are common, and function often is poor; because of these issues, it seems important to investigate alternative implants and surgical techniques.
QUESTIONS/PURPOSES: The purposes of this study were (1) to identify the frequency of surgical site complications and infection associated with the use of the Ice-Cream Cone prosthesis for reconstruction after hemipelvectomy for oncological indications; (2) to evaluate the Musculoskeletal Tumor Society (MSTS) outcomes scores in a small group of patients treated with this implant in the short term; and (3) to quantify the surgical margins and frequency of local recurrence in the short term in this group of patients.
Between 2008 and 2013, one center performed a total of 27 internal hemipelvectomies for oncological indications. Of those, 23 (85%) were treated with reconstruction. Our general indications for reconstruction were patients whose pelvic stability was affected by the resection and whose general condition was sufficiently strong to tolerate the reconstructive procedure. Of those patients undergoing reconstruction, 14 (61%) were treated with an Ice-Cream Cone-style implant (Coned; Stanmore Worldwide Ltd, Elstree, UK; and Socincer custom-made implant for the pelvis, Gijón, Spain), whereas nine others were treated with other implants or allografts. The indications during this time for using the Ice-Cream Cone implant were pelvic tumors affecting the periacetabular area without iliac wing involvement. Of those 14, 10 were available for followup at a minimum of 2 years (median, 3 years; range, 2-5 years) unless a study endpoint (wound complication, infection, or local recurrence) was observed earlier. Study endpoints were ascertained by chart review performed by one of the authors.
Surgical site complications occurred in five patients. Of those, two developed superficial infections with necrosis, two developed deep infections, and one patient developed wound necrosis without apparent infection. No prostheses were removed as a result of these complications [corrected]. Median MSTS score was 19 out of 30 when 0 is the worst possible result and 30 a perfect function and emotional status. Five of seven primary tumors had wide margin surgery and three of seven developed local recurrences by the end of the followup.
Pelvic reconstruction with the Ice-Cream Cone prosthesis yielded fair functional results at short-term followup. Longer term surveillance is called for to see whether this implant will represent an improvement over available reconstructive alternatives such as allograft, custom-made implants, and saddle prostheses. We are cautiously optimistic and continue to use this implant when we need to reconstruct the periacetabular area in patients without Enneking Zone 1 involvement.
Level IV, therapeutic study.
盆腔内半侧切除术切除后的重建可能比臀部截肢提供更好的功能。然而,已经使用了许多重建方法,这些方法的并发症很常见,而且功能往往很差;由于这些问题,研究替代植入物和手术技术似乎很重要。
问题/目的:本研究的目的是:(1)确定在肿瘤适应症的半侧盆腔切除术后使用“冰淇淋筒”假体进行重建相关的手术部位并发症和感染的发生率;(2)在一小群短期接受这种植入物治疗的患者中评估肌肉骨骼肿瘤学会(MSTS)的结果评分;(3)量化该组患者短期内的手术切缘和局部复发频率。
2008年至2013年间,一个中心共进行了27例肿瘤适应症的盆腔内半侧切除术。其中,23例(85%)接受了重建治疗。我们进行重建的一般适应症是盆腔稳定性受切除影响且一般状况足以耐受重建手术的患者。在接受重建的患者中,14例(61%)接受了“冰淇淋筒”式植入物(Coned;英国埃尔斯米尔的斯坦莫尔全球有限公司;以及西班牙希洪的Socincer定制骨盆植入物)治疗,而其他9例接受了其他植入物或同种异体移植。在此期间使用“冰淇淋筒”植入物的适应症是影响髋臼周围区域且未累及髂骨翼的盆腔肿瘤。在这14例患者中,10例至少随访了2年(中位数为3年;范围为2至5年),除非更早观察到研究终点(伤口并发症、感染或局部复发)。研究终点由作者之一通过病历审查确定。
5例患者发生了手术部位并发症。其中,2例发生浅表感染伴坏死,2例发生深部感染,1例患者发生伤口坏死但无明显感染。这些并发症均未导致假体取出[校正后]。MSTS评分中位数为30分中的19分,0分为最差结果,30分为完美功能和情绪状态。7例原发性肿瘤中有5例进行了广泛切缘手术,7例中有3例在随访结束时发生了局部复发。
在短期随访中,使用“冰淇淋筒”假体进行盆腔重建产生了尚可的功能结果。需要进行长期监测,以观察这种植入物是否会比同种异体移植、定制植入物和鞍形假体等现有重建替代方案有所改进。我们持谨慎乐观态度,并且在需要重建髋臼周围区域且患者未累及Enneking 1区时继续使用这种植入物。
IV级,治疗性研究。